We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AptarGroup Rides on Business Transformation Amid Inflation
Read MoreHide Full Article
On Aug 17, we issued an updated research report on AptarGroup, Inc. (ATR - Free Report) . The company is poised to gain from its focus on business-transformation plan, product roll-outs and the acquisition of CSP Technologies. However, rising costs might thwart the company’s margin performance.
Let’s illustrate these growth factors in detail.
CSP Technologies Acquisition to Fuel Growth
AptarGroup remains committed to expand its business through inorganic growth. In sync with this, the company recently made a binding offer to acquire CSP Technologies, a leader in active packaging technology based on proprietary material science expertise, for an enterprise value of $555 million. The proposed transaction is expected to close in fourth-quarter 2018.
This buyout will help AptarGroup fortify its existing business in the Pharma and Food Safety markets given that CSP Technologies' current business is roughly 75% in the pharma market and 25% in the food safety market.
Business-Transformation Plan to Stoke Growth
In late 2017, AptarGroup began a business-transformation plan to boost sales growth, increase operational excellence, enhance its approach to innovation and improve organizational effectiveness. The company remains on track with its business transformation which primarily focuses on the Beauty + Home segment. The business-transformation plan is expected to yield incremental EBITDA of approximately $80 million by the end of 2020, principally within the Beauty + Home segment.
AptarGroup to Grow on Product Roll Outs
AptarGroup is well poised to gain from product launches. It provided LVMH with customized dispensing solution for double serum facial skin care product in Europe. The company also designed a custom pump for Johnson & Johnson's major global relaunch of their iconic baby-care line, ranging from shampoo to bubble bath to lotion. AptarGroup’s Fine Mist pump, with prolonged spray technology, is also featured on a room refresher spray by J.R. Watkins.
Further, its preservative-free, multi-dose Ophthalmic Squeeze Dispenser was announced as the approved delivery device for Bausch+ Lomb's prescription Levofree Multidose in France. AptarGroup’s Advanced Preservative Free Plus pump for eye care is found on a new dry eye mist by Similasan in the CVS store brand in the United States. A muscle relaxer in Mexico, and a pain reliever and aesthetic products in North America have also been rolled out. Also, the company’s Flow Control silicone valve is performing very well.
Rising Costs to Impede Margins
AptarGroup expects to incur implementation costs of approximately $90 million over the next three years related to the business-transformation plan. It also anticipates capital investments of about $45 million for the plan, the majority of which will occur in 2018. These costs remain a drag for earnings in the near term. Further, rising resin prices will hurt margin performance.
Share Price Performance
AptarGroup has outperformed its industry with respect to price performance over the past year. The stock has gained around 26%, while the industry has recorded growth of 3%.
Zacks Rank & Stocks to Consider
AptarGroup currently carries a Zacks Rank #3 (Hold).
Actuant Corporation has an expected long-term growth rate of 15.6%. Its shares have gained 30% over the past year.
Caterpillar has an expected long-term growth rate of 13.3%. Its shares have been up 23% in a year’s time.
Lawson Products has an expected long-term growth rate of 17.5%. Its shares have rallied 34% over the past year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
Image: Bigstock
AptarGroup Rides on Business Transformation Amid Inflation
On Aug 17, we issued an updated research report on AptarGroup, Inc. (ATR - Free Report) . The company is poised to gain from its focus on business-transformation plan, product roll-outs and the acquisition of CSP Technologies. However, rising costs might thwart the company’s margin performance.
Let’s illustrate these growth factors in detail.
CSP Technologies Acquisition to Fuel Growth
AptarGroup remains committed to expand its business through inorganic growth. In sync with this, the company recently made a binding offer to acquire CSP Technologies, a leader in active packaging technology based on proprietary material science expertise, for an enterprise value of $555 million. The proposed transaction is expected to close in fourth-quarter 2018.
This buyout will help AptarGroup fortify its existing business in the Pharma and Food Safety markets given that CSP Technologies' current business is roughly 75% in the pharma market and 25% in the food safety market.
Business-Transformation Plan to Stoke Growth
In late 2017, AptarGroup began a business-transformation plan to boost sales growth, increase operational excellence, enhance its approach to innovation and improve organizational effectiveness. The company remains on track with its business transformation which primarily focuses on the Beauty + Home segment. The business-transformation plan is expected to yield incremental EBITDA of approximately $80 million by the end of 2020, principally within the Beauty + Home segment.
AptarGroup to Grow on Product Roll Outs
AptarGroup is well poised to gain from product launches. It provided LVMH with customized dispensing solution for double serum facial skin care product in Europe. The company also designed a custom pump for Johnson & Johnson's major global relaunch of their iconic baby-care line, ranging from shampoo to bubble bath to lotion. AptarGroup’s Fine Mist pump, with prolonged spray technology, is also featured on a room refresher spray by J.R. Watkins.
Further, its preservative-free, multi-dose Ophthalmic Squeeze Dispenser was announced as the approved delivery device for Bausch+ Lomb's prescription Levofree Multidose in France. AptarGroup’s Advanced Preservative Free Plus pump for eye care is found on a new dry eye mist by Similasan in the CVS store brand in the United States. A muscle relaxer in Mexico, and a pain reliever and aesthetic products in North America have also been rolled out. Also, the company’s Flow Control silicone valve is performing very well.
Rising Costs to Impede Margins
AptarGroup expects to incur implementation costs of approximately $90 million over the next three years related to the business-transformation plan. It also anticipates capital investments of about $45 million for the plan, the majority of which will occur in 2018. These costs remain a drag for earnings in the near term. Further, rising resin prices will hurt margin performance.
Share Price Performance
AptarGroup has outperformed its industry with respect to price performance over the past year. The stock has gained around 26%, while the industry has recorded growth of 3%.
Zacks Rank & Stocks to Consider
AptarGroup currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the sector include Actuant Corporation , Caterpillar Inc. (CAT - Free Report) and Lawson Products, Inc. . All three stocks sport Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Actuant Corporation has an expected long-term growth rate of 15.6%. Its shares have gained 30% over the past year.
Caterpillar has an expected long-term growth rate of 13.3%. Its shares have been up 23% in a year’s time.
Lawson Products has an expected long-term growth rate of 17.5%. Its shares have rallied 34% over the past year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>